ARTROL DIN 00109908
Health Canada record
| Active ingredient(s) | ANTIPYRINE 142 MG; SODIUM SALICYLATE 811 MG; SODIUM BICARBONATE 73 MG; METHYL SALICYLATE .0114 ML; CIMICIFUGA RACEMOSA 266 MG; TARAXACUM OFFICINALE WEBER 355 MG |
|---|---|
| Dosage form | Liquid |
| Route | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Human |
| ATC | N02BB51 PHENAZONE, COMBINATIONS EXCL PSYCHOLEPTICS |
| Original market date | 31-Dec-1968 |
| Current status date | 02-Jan-2008 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ANTIPYRINE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02332477 | AURALGAN | PALADIN PHARMA INC. | Solution | ANTIPYRINE 54 MG; BENZOCAINE 14 MG | Cancelled Post Market |
| 01932403 | AURALGAN SOLUTION | WYETH CONSUMER HEALTHCARE INC. | Solution | ANTIPYRINE 54 MG; BENZOCAINE 14 MG | Cancelled Post Market |
| 02077329 | HOMEOPATHIC MEDICINE (S NO. 313) DPS 30C | TOTAL HEALTH CENTRE | Drops | ANTIPYRINE 30 C | Cancelled Post Market |
| 00540943 | OTI CAL | PRODUITS FRANCAIS LABS INC. | Drops | ANTIPYRINE 58 MG; BENZOCAINE 15.3 MG | Cancelled Post Market |
International API supply for ANTIPYRINE
0 active FDA Drug Master Files.
Request a quote for ARTROL